These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 2934516)
1. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery. Battaglia G; Norman AB; Newton PL; Creese I J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516 [TBL] [Abstract][Full Text] [Related]
2. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Hamblin MW; Creese I Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202 [TBL] [Abstract][Full Text] [Related]
3. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites. Pinto W; Battaglia G Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861 [TBL] [Abstract][Full Text] [Related]
4. Irreversible antagonism of 5HT2c receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ). Ni YG; Camacho N; Miledi R Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2715-8. PubMed ID: 9122262 [TBL] [Abstract][Full Text] [Related]
5. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain. Norman AB; Creese I Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499 [TBL] [Abstract][Full Text] [Related]
6. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover. Keck BJ; Lakoski JM Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817 [TBL] [Abstract][Full Text] [Related]
7. Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Leysen JE; Van Gompel P; Gommeren W; Woestenborghs R; Janssen PA Psychopharmacology (Berl); 1986; 88(4):434-44. PubMed ID: 3010361 [TBL] [Abstract][Full Text] [Related]
8. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro. Hess EJ; Battaglia G; Norman AB; Creese I Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940 [TBL] [Abstract][Full Text] [Related]
9. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist. Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558 [TBL] [Abstract][Full Text] [Related]
10. Regional heterogeneity of serotonin(1A) receptor inactivation and turnover in the aging female rat brain following EEDQ. Keck BJ; Lakoski JM Neuropharmacology; 2000 Apr; 39(7):1237-46. PubMed ID: 10760365 [TBL] [Abstract][Full Text] [Related]
11. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain. Xu SX; Hatada Y; Black LE; Creese I; Sibley DR J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain. Gozlan H; Laporte AM; Thibault S; Schechter LE; BolaƱos F; Hamon M Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280 [TBL] [Abstract][Full Text] [Related]
13. Modification of gamma-aminobutyric acidA receptor binding and function by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vitro and in vivo: effects of aging. Miller LG; Lumpkin M; Galpern WR; Greenblatt DJ; Shader RI J Neurochem; 1991 Apr; 56(4):1241-7. PubMed ID: 1848276 [TBL] [Abstract][Full Text] [Related]
14. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists. Giorgi O; Biggio G Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234 [TBL] [Abstract][Full Text] [Related]
15. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists. Meller E; Goldstein M; Bohmaker K Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates. Alper RH; Nelson DL Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708 [TBL] [Abstract][Full Text] [Related]
17. Modulation of the serotonin S2-receptor in brain after chronic lithium. Wajda IJ; Banay-Schwartz M; Manigault I; Lajtha A Neurochem Res; 1986 Jul; 11(7):949-57. PubMed ID: 2944024 [TBL] [Abstract][Full Text] [Related]
18. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade. Henry JM; Roth GS Life Sci; 1984 Aug; 35(8):899-904. PubMed ID: 6482680 [TBL] [Abstract][Full Text] [Related]
19. Lack of apparent receptor reserve at postsynaptic 5-hydroxytryptamine1A receptors negatively coupled to adenylyl cyclase activity in rat hippocampal membranes. Yocca FD; Iben L; Meller E Mol Pharmacol; 1992 Jun; 41(6):1066-72. PubMed ID: 1352034 [TBL] [Abstract][Full Text] [Related]
20. Differential effect of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on [3H]SCH23390 and [3H]forskolin binding in rat striatum. Norman AB; Wachendorf TJ; Sanberg PR Life Sci; 1989; 44(13):831-6. PubMed ID: 2648096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]